• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazole carboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles Pyrazole carboxylic acids and derivatives

Introduction to 5-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid (CAS No. 854405-74-6)

5-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry due to its unique structural properties and potential biological activities. This compound, identified by the CAS number 854405-74-6, belongs to the pyrazole class of molecules, which are well-known for their broad spectrum of pharmacological applications. The presence of a cyclopentane ring fused with a pyrazole moiety introduces additional complexity and functionality, making it a promising candidate for further investigation in drug discovery.

The molecular structure of 5-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid features a carboxylic acid group at the 3-position of the pyrazole ring, which is a key functional moiety that can participate in various chemical reactions and biological interactions. The methyl substituent at the 5-position of the cyclopentane ring further influences the electronic and steric properties of the molecule, potentially modulating its biological activity. This structural arrangement makes it an intriguing subject for synthetic chemists and pharmacologists alike.

In recent years, there has been growing interest in developing novel heterocyclic compounds for therapeutic applications. Pyrazole derivatives, in particular, have been extensively studied due to their ability to interact with biological targets such as enzymes and receptors. The cyclopentane ring in 5-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid adds an additional layer of complexity, which can be exploited to design molecules with enhanced selectivity and potency. This compound has shown promise in preliminary studies as a scaffold for developing new drugs targeting various diseases.

One of the most compelling aspects of 5-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid is its potential as a building block for more complex molecules. The carboxylic acid group can be easily modified through esterification or amidation reactions to introduce different pharmacophores or improve solubility. Additionally, the pyrazole ring can be further functionalized to enhance binding affinity to biological targets. These characteristics make it a versatile tool for medicinal chemists seeking to develop novel therapeutic agents.

Recent advancements in computational chemistry have also facilitated the study of 5-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid by allowing researchers to predict its biological activity and optimize its structure. Molecular docking studies have suggested that this compound may interact with several key enzymes and receptors involved in inflammatory pathways and cancer progression. These findings align with ongoing research efforts aimed at identifying new targets for drug development.

The synthesis of 5-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid has been reported by several research groups using multi-step organic synthesis approaches. The key steps typically involve cyclization reactions to form the cyclopentane-pyrazole core followed by functionalization at the desired positions. These synthetic routes highlight the compound's accessibility and feasibility for large-scale production if needed.

In conclusion, 5-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid (CAS No. 854405-74-6) represents a fascinating molecule with significant potential in pharmaceutical research. Its unique structural features and preliminary biological activity make it a valuable candidate for further exploration in drug discovery programs. As our understanding of heterocyclic chemistry continues to evolve, 5-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid is likely to play an important role in the development of new therapeutic agents targeting various diseases.

• 792952-01-3(1H-Indazole-3-carboxylicacid, 4,5,6,7-tetrahydro-4-methyl-7-(1-methylethyl)-)
• 5932-32-1(1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid)
• 856256-55-8(4-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid)
• 856256-49-0(6-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylic acid)
• 842972-14-9(5-Methyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic acid)
• 949034-52-0(2,4,5,6-tetrahydro-6-methyl-3-Cyclopentapyrazolecarboxylic acid)
• 650603-95-5(5-tert-butyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxylic Acid)
• 949034-58-6(2,4,5,6-tetrahydro-5-methyl-3-Cyclopentapyrazolecarboxylic acid)
• 6076-13-7(4,5,6,7-Tetrahydro-1H-indazole-3-carboxylic acid)
• 884497-47-6(3-Cyclopentapyrazolecarboxylicacid, 2,4,5,6-tetrahydro-)